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Background: Strong associations have been observed between exposure to fine ambient particulate matter (PM2.5)
and adverse cardiovascular outcomes. In particular, exposure to traffic related PM2.5 has been associated with
increases in left ventricular hypertrophy, a strong risk factor for cardiovascular mortality. As much of traffic related
PM2.5 is derived from diesel exhaust (DE), we investigated the effects of chronic DE exposure on cardiac
hypertrophy and heart failure in the adult mouse by exposing mice to DE combined with either of two mouse
models of cardiac hypertrophy: angiotensin II infusion or pressure overload induced by transverse aortic banding.
Methods: Wild type male C57BL/6 J mice were either infused with angiotensin II (800 ng/kg/min) via osmotic
minipump implanted subcutaneously for 1 month, or underwent transverse aortic banding (27 gauge needle
1 week for observing acute reactions, 26 gauge needle 3 months or 6 months for observing chronic reactions).
Vehicle (saline) infusion or sham surgery was used as a control. Shortly after surgery, mice were transferred to our
exposure facility and randomly assigned to either diesel exhaust (300 or 400 μg/m3) or filtered air exposures. After
reaching the end of designated time points, echocardiography was performed to measure heart structure and
function. Gravimetric analysis was used to measure the ventricular weight to body weight ratio. We also measured
heart rate by telemetry using implanted ambulatory ECG monitors.
Results: Both angiotensin II and transverse aortic banding promoted cardiac hypertrophy compared to vehicle or
sham controls. Transverse aortic banding for six months also promoted heart failure in addition to cardiac
hypertrophy. In all cases, DE failed to exacerbate the development of hypertrophy or heart failure when compared
to filtered air controls. Prolonged DE exposure also led to a decrease in average heart rate.
Conclusions: Up to 6-months of DE exposure had no effect on cardiac hypertrophy and heart function induced by
angiotensin II stimulation or pressure overload in adult C57BL/6 J mice. This study highlights the potential
importance of particle constituents of ambient PM2.5 to elicit cardiotoxic effects. Further investigations on particle
constituents and cardiotoxicity are warranted.
Keywords: Diesel exhaust, PM2.5, Air pollution, Cardiac hypertrophy, Heart failure* Correspondence: mtchin@u.washington.edu
1Division of Cardiology, Department of Medicine, University of Washington,
Seattle, WA, USA
3Center for Cardiovascular Biology, University of Washington School of
Medicine, 850 Republican Street, Room 353, Box 358050, Seattle 98109, WA,
USA
Full list of author information is available at the end of the article
© 2013 Liu et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Liu et al. Particle and Fibre Toxicology 2013, 10:49 Page 2 of 11
http://www.particleandfibretoxicology.com/content/10/1/49Background
There is extensive evidence from epidemiological inves-
tigations that acute and chronic exposure to fine ambi-
ent particulate matter (PM2.5) is associated with an
increased risk of cardiovascular morbidity and mortality
[1-5]. The biological mechanisms of PM2.5-mediated
cardiotoxicity are still under active investigation, but re-
cent studies have highlighted the potential for PM2.5 in-
halation to impact cardiac hypertrophy and contractility
[6-9]. In many urban regions, PM2.5 is largely derived
from diesel exhaust (DE) [10], thus controlled exposure
systems utilizing DE have been routinely used to investi-
gate the cardiovascular effects of PM2.5 inhalation in
both humans [11-14] and animals [15-20]. These studies
have provided evidence that inhalation of DE can in-
crease blood pressure [14], increase left ventricular is-
chemia [12], decrease vascular nitric oxide bioavailability
[18,19], cause vasoconstriction [13], and increase sensi-
tivity to vasoconstricting agents [18]. Although these
systemic effects are believed to contribute to vascular
disease, there is mounting evidence that these effects
can result in cardiac hypertrophy in human populations.
Investigations by Van Hee and colleagues [7,8] have
demonstrated that living in close proximity to a major
roadway results in an increased exposure to PM2.5 and
is associated with an increase in left ventricular mass.
Left ventricular hypertrophy is an important predictor of
cardiovascular mortality and can be a maladaptive re-
sponse to increased blood pressure and left ventricular
ischemia. In support of the role of particulate air pollution
in causing this hypertrophic effect, evidence from Ying
and colleagues [6] have shown that a 3-month expos-
ure to concentrated ambient particulate matter (CAPs)
in mice causes an exacerbation of a subsequent angio-
tensin II-induced cardiac hypertrophy in a Rho kinase
dependent manner. Additionally, Wold and colleagues
[9] have reported that a 9-month exposure to CAPs re-
sults in increased ventricular size along with systolic
and diastolic dysfunction. In each of these studies,
CAPs were collected from the Columbus, Ohio region,
resulting in a particulate exposure that is a complex
mixture from many sources. Currently, there are no
studies to date investigating the acute and chronic ef-
fects of DE exposure alone on cardiac hypertrophy and
failure. Here, we hypothesized that acute (1 week) and
chronic (1, 3 and 6 months) exposure to DE (300 or
400 μg/m3, 6 hr/day, 5 days/week) would result in an
exacerbation of cardiac hypertrophy and failure in mice
when exposure occurred simultaneously with angiotensin
II (Ang II) infusion or transverse aortic constriction
(TAC).
In the work presented here, we report that DE expos-
ure failed to have any significant effect on susceptibility
to cardiac hypertrophy or failure in either the Ang IIinfusion or TAC models of heart failure following a 1-
week, 1-month, 3-month, or 6-month exposure. These
observations lead us to conclude that the observed
effects on PM2.5-induced hypertrophy may be a unique
response to the complex exposure in CAPs, whereas DE
alone is insufficient. These data highlight the need for
continued investigation into multi-pollutant models of
air pollution and their potential effects on cardiac hyper-
trophy and failure.
Results
Effects of diesel exhaust exposure combined with
angiotensin II infusion
To test the effect of DE exposure on cardiac hypertrophy
induced by Ang II, we implanted osmotic minipumps
for the infusion of Ang II or saline vehicle and then ex-
posed mice to either DE or filtered air (FA). Echocardi-
ography measurements and gravimetric analysis were
performed after 1 month. As expected, there were in-
creases in left ventricular wall thickness (LV WT) and
ventricular weight to body weight ratio (VW/BW) in
Ang II infusion groups compared with vehicle groups
with both DE and FA exposures (Figure 1A and B), but
there were no differences between DE exposed mice
and FA controls (Figure 1A and B). Left ventricular
ejection fraction (LVEF) was not affected by Ang II or
DE (Figure 1D). Left ventricle end diastolic dimension
(LVEDD) was mildly increased by angiotensin II in the
DE exposed animals compared to vehicle controls but
there was no effect of angiotensin II exposure in FA
exposed animals (Figure 1C).
Effects of short-term diesel exhaust exposure combined
with acute pressure overload
We performed transverse aortic banding on wild type
C57BL/6 J mice with a 27 g needle to induce cardiac
hypertrophy and exposed the mice to 400 μg/m3 ozone
treated DE or FA for 1 week. After the procedures, VW/
BW and LV wall thickness trended towards an increase
in transverse aortic banding groups compared with sham
groups but there was no difference between DE and FA
exposure groups (Figure 2A,B). Measurement of heart
function and LV chamber size after transverse aortic
banding suggested a trend towards an increase in LVEDD
and a decrease in LVEF when compared to sham operated
controls but these changes did not reach statistical signifi-
cance. We also observed no trend or significant differ-
ences in LVEDD or LVEF between DE and FA exposure
groups (Figure 2C,D). Our sample size is small, however,
and we cannot absolutely rule out type II error. To ad-
dress this issue we performed a sample size calculation to
determine what sample size would be needed to achieve
sufficient statistical power to determine whether the slight



























































































Figure 1 Effects of diesel exhaust exposure and angiotensin II on cardiac hypertrophy. Angiotensin II was infused (800 ng/kg/min) via
osmotic minipump in conjunction with either DE (300 μg/m3, non-ozone treated) or FA exposure for 4 weeks (6 hr/day, 5 days/week). A.
Ventricular weight to body weight ratio (VW/BW). N = 8 for all groups. B. Left ventricular wall thickness (LV WT). N = 10 for all groups. C. Left
ventricular end diastolic dimension (LVEDD). N = 10 for all groups. D. Left ventricular ejection fraction (LVEF). N = 10 for all groups. FA: filtered air.
DE: diesel exhaust.
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is impractical, and suggests that any significant effect of
diesel exhaust would likely be exceedingly small if present
at all.
Effects of long-term diesel exhaust exposure combined
with chronic pressure overload
Since we failed to observe a difference in acute exposure
experiments, we investigated the effects of prolonged
diesel exposure on TAC induced cardiac hypertrophy.
We used a 26 g needle for the transverse aortic banding
to allow survival of the mice for the duration of the DE
exposure. After surgery, mice were exposed to either
300 μg/m3 non-ozone treated DE or FA for 3 months.
At the end of the study period, VW/BW showed a trend
towards an increase in transverse aortic banding groups
compared with sham operated groups but there was no
difference between DE and FA groups (Figure 3A). Inter-
estingly, there was a trend towards increased LV wall
thickness after banding in the FA controls that was not
seen in the DE exposed animals (Figure 3B), while there
was a trend towards increased LV chamber size afterTAC in the DE exposed animals that was not seen in the
FA controls (Figure 3C). There was also a trend towards
a decrease in LVEF in the TAC groups compared to
sham operated groups, and also a trend towards de-
creased LVEF in the DE TAC group compared to the FA
TAC and FA sham groups, but these trends were not
statistically significant (Figure 3D). Our sample size is
small, so we performed sample size calculations to deter-
mine the number of animals needed to demonstrate
significant differences if these effects were real, and de-
termined that we would need a group size of 68 for
LVEDD and 60 for LVEF to see a difference between
FA TAC and DE TAC. Although we cannot absolutely
rule out type II error, these findings again indicate that
any significant effect of diesel exhaust would likely be
exceedingly small if present at all.
To determine whether a more prolonged exposure to
diesel exhaust would demonstrate significant effects on
hypertrophy and ventricular function, we extended the
exposure time to 6 months and repeated the study.
Again, we performed 26 g transverse aortic banding on






























































































Figure 2 Effects of short-term diesel exhaust exposure and acute pressure overload on cardiac hypertrophy. Transverse aortic banding
(27 gauge needle) was done in conjunction with DE (400 μg/m3, ozone treated) or FA exposure for one week (6 hr/day, 5 days/week). A.
Ventricular weight to body weight ratio (VW/BW). FA/sham: n = 3; FA/banding: n = 5; DE/sham: n = 3; DE/banding: n = 5. B. Left ventricular wall
thickness (LV WT). FA/sham: n = 2; FA/banding: n = 3; DE/sham: n = 3; DE/banding: n = 5. C. Left ventricular end diastolic dimension (LVEDD). FA/
sham: n = 2; FA/banding: n = 3; DE/sham: n = 3; DE/banding: n = 5. D. Left ventricular ejection fraction (LVEF). FA/sham: n = 2; FA/banding: n = 3;
DE/sham: n = 3; DE/banding: n = 5. FA: filtered air. DE: diesel exhaust.
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or FA. After the procedures, VW/BW increased signifi-
cantly in TAC groups compared with sham groups, but
there was no effect of DE compared to FA (Figure 4A). LV
WT increased after TAC, however, there was no difference
between DE and FA exposure (Figure 4B). LVEDD showed
a trend towards enlargement in the TAC groups with a
trend towards exacerbation by DE exposure, but the dif-
ferences were not statistically significant (Figure 4C).
LVEF decreased significantly after aortic banding in
both DE and FA groups (Figure 4D), but there were no
significant differences between DE and FA exposure
groups.Effects of long-term diesel exhaust exposure on
heart rate
As expected, there were no changes in HR during the
week of FA for any of the groups. With DE exposure,
there was a significant decrease in HR that persisteduntil the DE exposure concluded. There was slight re-
covery of HR in the post-exposure weeks (Figure 5).
Interestingly, there was no dose–response relationship
noted. A similar decrease was noted following exposure
to all three doses of DE, with no significant difference be-
tween the three doses. There was greater apparent vari-
ability noted in the DE200 group, but this is due to the
smaller study group and not actual increased variability.Discussion
In this study, we investigated the hypothesis that the in-
halation of DE under both acute (1-week, 1-month) and
chronic (3-month, 6-month) conditions would exacer-
bate the progression of cardiac hypertrophy and failure
in two models of cardiac hypertrophy in mice. Although
there is strong evidence that exposure to traffic related
air pollution results in increased left ventricular mass in
humans [7,8], and results in increased hypertrophy as
































































































Figure 3 Effects of 3 months of diesel exhaust exposure and chronic pressure overload on cardiac hypertrophy. Transverse aortic
banding (26 gauge needle) was done in conjunction with DE (300 μg/m3, non-ozone treated) or FA exposure for 3 months (6 hr/day, 5 days/
week). A. Ventricular weight to body weight ratio (VW/BW). B. Left ventricular wall thickness (LV WT). C. Left ventricular end diastolic dimension
(LVEDD). D. Left ventricular ejection fraction (LVEF). FA/sham: n = 4; FA/banding: n = 2; DE/sham: n = 4; DE/banding: n = 3. FA: filtered air. DE:
diesel exhaust.
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hypertrophic or contractile responses in two mouse
models of cardiac hypertrophy.
We did observe a paradoxical effect of DE exposure
on heart rate. In epidemiological studies, the general
consensus is that HR increases while measures of HRV
decrease in humans exposed to PM [4]. However, we see
the opposite effect in this study. The reason for this may
be due to differences between rodents and humans.
Other studies have seen similar results with exposure to
CAPs [21] and carbon black [22]. It is possible that al-
though the autonomic nervous system (ANS) is affected
by the DE exposure, afferent ANS pathways differ in
mice from those in humans.
There are some caveats to our study. Although we do
not observe any effects of DE exposure on hypertrophy
or heart function at the organ level, it is possible that ac-
tivation of pathways at the molecular level has occurred.
Even if these changes are occurring, however, the lack of
response at the organ level indicates that these hyper-
trophy models and this exposure system may be limited
in their utility for studying cardiovascular pathogeneticmechanisms induced by DE exposure. Another caveat is
that our echocardiographic assessment was done from
1–7 days after diesel exposure was terminated, and we
cannot rule out short lived effects on cardiac function
that disappear rapidly after exposure is terminated.
Others have found, however, that CAP exposure can
lead to significant effects on cardiac function two weeks
after the exposure is terminated [6]. Using the same ex-
posure facility and conditions described here, we have
also found that exposure to DE exhaust in utero and
early in life can predispose to hypertrophy in adults,
long after the exposure is terminated (Weldy CS et al.,
manuscript submitted). Another caveat to our study is
that we did not measure blood pressure in the animals
that were treated with Angiotensin II, and there is a pos-
sibility that the minipumps failed to deliver appropriate
amounts. Our observation of Ang II induced increases
in VW/BW and LV WT in Figure 1 is strongly indicative
that Ang II was infused appropriately. Angiotensin II is
also known to promote cardiac hypertrophy at subpressor
doses, obviating the need for blood pressure monitoring































































































Figure 4 Effects of 6 months of diesel exhaust exposure and chronic pressure overload on cardiac hypertrophy. Transverse aortic
banding (26 gauge needle) was done in conjunction with DE (300 μg/m3, non-ozone treated) or FA exposure for 6 months (6 hr/day, 5 days/week). A.
Ventricular weight to body weight ratio (VW/BW). B. Left ventricular wall thickness (LV WT). C. Left ventricular end diastolic dimension (LVEDD). D. Left
ventricular ejection fraction (LVEF). FA/Sham: n = 11; FA/Banding: n = 10; DE/Sham: n = 8; DE/Banding: n = 9. FA: filtered air. DE: diesel exhaust.
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mice. We and others have shown that similar exposures
using our facility result in low level neutrophilic airway in-
flammation [24] and systemic lipid peroxidation [25]. We

















Figure 5 Effects of diesel exhaust exposure on heart rate. Change from
to FA followed by 100, 200, or 400 μg/m3 of DE for eight weeks (D1 – D8)
(P1 – P3). No data was collected for the group exposed to 200 μg/m3 after
to FA.Controlled exposures to DE in both human and ani-
mal studies have been used routinely to model ambient
PM2.5 exposure. The benefits of using DE have been the
relative ease of reproducible and well-defined exposures








baseline heart rate levels in beats per minute (BPM) during exposure
and in the three weeks following that where there was no exposure
D8. Data represent the mean +/− SEM. * p-value < 0.05 compared
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jority of ambient PM2.5 is derived from diesel engines,
thus DE exposures are largely mimicking ambient expo-
sures to urban and traffic related particulate air pollu-
tion. Studies utilizing collected diesel exhaust particulate
(DEP) in both in vitro and in vivo exposures have dem-
onstrated their robust proinflammatory effects and their
strong potential to influence systemic vascular function
[26-29], but there is strong evidence to suggest that the
inflammatory and toxic potential of these particles is
influenced by additional particulate constituents, such as
endotoxin and metals.
The disadvantage of using DE is that it is a relatively
‘simple’ exposure model, in that the PM2.5 resulting from
DE is mostly carbonaceous in nature, containing poly-
cyclic aromatic hydrocarbons and redox active quinones,
but lacking many other contaminants important to par-
ticulate matter toxicity. In the work reported in Ying
et al. [6] and Wold et al. [9], they report their observed
effects on cardiac hypertrophy and failure after exposure
to CAPs from the Columbus, Ohio region. In both of
these studies, exposures were done using ambient par-
ticulate material that was concentrated directly from the
atmosphere, resulting in an exposure that consists of
PM2.5 from traffic related sources such as diesel exhaust,
but also from jet fuel (as an airport is near the exposure
site), agriculture (which may result in endotoxin expos-
ure), as well as coal fired power plants and other indus-
trial sources of PM2.5. The advantage of these CAPs
studies is that the PM2.5 exposures closely match the hu-
man exposures in the population. The main disadvan-
tage is that these exposures are difficult to compare
across institutions as PM2.5 composition will vary widely
across regions and proximity to sources, and the PM2.5
composition during the exposure may vary from day-to-day
depending on the magnitude of PM2.5 emissions near the
exposure site.
The results from the studies reported here suggest that
a DE exposure in C57BL/6 J mice up to 6 months in
length has no effect on the cardiac hypertrophic or func-
tional responses in Ang II infusion or TAC models of
heart failure. That we do not observe any effect in these
studies whereas others have reported effects using CAPs
suggests that either 1) 6 months exposure to DE is not
enough time to see any effect, or 2) DE exposures are
lacking PM constituents found in CAPs that provide for
their unique cardiotoxicity.
It is possible that a 6 month exposure to DE is not
enough time to elicit the hypertrophic or functional ef-
fects on the mouse heart. In the report published by
Wold et al. [9], their CAP exposure was for 9 months,
and this exposure resulted in increased expression of
hypertrophic markers, decreased fractional shortening,
diastolic dysfunction and decreased contractile reserve,consistent with heart failure. In our exposures, diesel ex-
haust concentration is dynamically regulated to 300 μg/m3,
6 hrs a day, 5 days a week. Since mice are exposed to FA
for 18 hrs a day, and during weekends, our total time
weighted average exposure for the 6 month period is
expected to be ~53 μg/m3/hr. We calculate cumulative ex-
posure, using concentration x time, to be 53 μg/hr ×
6 months × 30 days/month × 24 hrs/day = 228960 μg/m3.
In the study by Wold et al. [9], they calculated a time
weighted average exposure to be 15 μg/m3/hr. The calcu-
lated cumulative exposure over 9 months is 15 μg/m3 ×
9 months × 30 days/month × 24 hrs/day = 97200 μg /m3.
In our assessment, our cumulative exposure to PM2.5 in
6 months is 2.36 times greater than their exposure in
9 months. This suggests to us that our inability to find any
significant effect on cardiac hypertrophy or function with
our 6-month DE exposure must be due to either 1) constit-
uents of CAPs within the Wold et al. study that elicit
greater cardiotoxicity than PM2.5 from DE, or 2) duration
of PM2.5 exposure is more important than cumulative ex-
posure. Although, from this assessment, we cannot rule
out the possibility that the duration of exposure is the crit-
ical component to observing cardiotoxicity, we believe this
is unlikely, as our 2.36 times greater cumulative PM2.5 ex-
posure would be expected to elicit a more rapid acceler-
ation of cardiac hypertrophy and failure. In addition,
although Wold et al. [9] had a longer exposure time than
the studies reported here, Ying et al. [6] exposed mice to
CAPs for only 3 months, and then assessed their suscepti-
bility to Ang II-induced cardiac hypertrophy. They ob-
served the 3-month CAPs exposure to promote cardiac
remodeling induced by a two-week infusion of Ang II
through a Rho kinase dependent mechanism. The report
by Ying et al. [6] suggests that a 3-month exposure to
CAPs is sufficient to observe these adverse effects resulting
from Ang II infusion. In this study, their cumulative PM2.5
exposure was 15 μg/m3/hr × 3 months × 30 days/month ×
24 hrs/day = 32400 μg/m3. Our study has a cumulative ex-
posure that is 7 times greater than their study, further
suggesting that our lack of finding a significant effect is
likely due to diesel exhaust particulate lacking PM constit-
uents that elicit unique responses to the myocardium.
There is a growing belief that particular constituents
of ambient PM2.5 likely have important modifications
to their toxicity within human populations. In a recent
report by Wu et al. [30], acute PM2.5 exposures in a
Chinese population were associated with increases in
systolic as well as diastolic blood pressure, and these
increases in BP were found to be positively modified by
PM2.5 constituents such as carbonaceous fractions,
ions, and metals. In addition, a recent report by Kim et al.
[31] observed PM2.5 constituents such as sulfate and
nitrate to alter their observed temporal relationships
between increases in PM2.5 and hospital admissions.
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toxic and proinflammatory effects have been investi-
gated in vitro, where the presence of metals such as
arsenic, zinc, chromium, copper, manganese, and iron
have been found to be positively associated with deleteri-
ous effects [32-35]. As the cytotoxic and proinflammatory
effects of PM2.5 have been suggested to be largely me-
diated by the generation of reactive oxygen species and
subsequent oxidative stress, it is likely the case that
metal constituents that can participate in redox cycling
and Fenton chemistry are capable of enhancing PM2.5
toxicity. As we do not observe a chronic DE exposure
(which is largely carbonaceous, containing low metal
content) to elicit changes in cardiac hypertrophy or
function, it is possible that metal constituents within
CAPs are likely enhancing PM2.5 effects on pulmonary
and systemic inflammation, potentially driving these
changes in ventricular remodeling. These observations
may suggest that a certain ‘threshold’ of inflammation
and oxidative stress is required to be exceeded before
changes in cardiac size or function will be observed. In
support of this hypothesis, it has been recently reported
that rapid, high dose exposures of collected DEP to
rats via intranasal nebulization over a 5-week period
can elicit cardiac dysfunction and remodeling [35],
suggesting that DEP may be able to elicit these effects,
but it may require extremely high doses, rapid admin-
istration, and lengthy exposure times that exceed what
would be required when particle constituents within
CAPs are included.
Conclusions
Here, we report that a DE exposure (300 μg/m3, 6 hr/day,
5 days/week for up to 6 months) has no effect on cardiac
hypertrophy and function in two models of cardiac hyper-
trophy. These observations suggest that the specific effects
that have been previously reported on PM2.5 on cardiac
hypertrophy and heart failure may be due to unique PM
constituents found in complex mixtures of ambient PM2.5,
but not in DE. Ambient particulate air pollution is an im-
portant public health concern. In the most recent Global
Burden of Disease report, ambient particulate air pollution
is the #9 cause of disease worldwide [36]. Regulatory pol-
icies and guidelines will need to take into account the
complexity of PM2.5 exposures across regions and will
need to evaluate the importance of multi-pollutant models
of air pollution. Further investigation is needed to under-




Wild type male C57BL/6 J mice (10 weeks old for angio-
tensin II infusion and 12 weeks old for transverse aorticbanding surgery) were used for these studies. Mice were
obtained from Jackson Laboratories (Bar Harbor, ME).
The studies were conducted according to guidelines and
protocols approved by the University of Washington In-
stitutional Animal Care and Use Committee.
Angiotensin II infusion
Angiotensin II (Ang II) or vehicle (saline) was infused
continuously through a subcutaneously implanted os-
motic minipump (Alzet 1004, DURECT Corporation,
Cupertino, CA) as previously described [37,38]. The Ang
II infusion rate was 800 ng/kg/min for 4 weeks. Shortly
after surgery, mice were transferred to the diesel expos-
ure facility, where they were exposed to either DE
(300 μg/m3, non-ozone treated) or filtered air (FA) for
6 hours per day, 5 days per week for 4 weeks. After the ex-
posure, mice were housed in room air for 1 week before
echocardiographic assessment and gravimetric analysis.
Transverse aortic banding
Mice underwent transverse aortic banding surgery or
sham surgery as previously described [39-41]. For short
term exposure experiments, transverse aortic banding
was performed using a 27 gauge needle followed by ei-
ther DE exposure (400 μg/m3, ozone treated), or FA ex-
posure for 6 hours per day, 5 days per week, for 1 week.
Echocardiography was performed 9 days after the sur-
gery and gravimetric analysis was performed 10 days
after the surgery.
For the chronic exposure experiments, transverse aor-
tic banding was performed using a 26 gauge needle
followed by either DE exposure (300 μg/m3, non-ozone
treated) or FA exposure for 6 hours per day, 5 days per
week for either 3 or 6 months. Echocardiography and
gravimetric analyses were performed 3 or 6 months after
the surgery.
Diesel exhaust exposure
Following minipump implantation or TAC surgery, mice
were transferred to our diesel exposure facility where ex-
posures to either FA or DE were conducted simultan-
eously in an Allentown caging system (Allentown, NJ,
USA) under SPF conditions. DE (300 or 400 μg/m3) was
generated from a single cylinder Yanmar diesel engine
(model YDG5500EV-6EI) operating on 75% load as pre-
viously described [20,42,43]. The stability of the PM2.5
concentration is maintained by an elaborate feedback
control system [42]. Exposures were 6 hr/day, 5 days/
week, producing roughly a 50 μg/m3/hr cumulative time
weighted average exposure. A DE exposure concentra-
tion of 300 μg/m3 was chosen as this is a relevant expos-
ure concentration in certain occupational settings such
as mining [44], and is consistent with prior studies in-
vestigating the vascular effects of acute DE inhalation
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term TAC study to provide the maximum possible DE
exposure. In that same study, we also treated the DE
particles with ozone to mimic atmospheric conditions
and enhance the toxicity of the particles. No ozone was
introduced into the exposure chamber. In our system,
we generally observe carbon monoxide concentrations
of 2 ppm at 300 μg/m3 PM2.5. At this PM concentration,
NO2 is generally 6 ppb, while total NOx is approximately
1700 ppb. Most of the NOx is in the form of NO, due to
lack of exposure to sunlight in our system. We do not
expect these gaseous components to affect heart failure
progression. In general, our DE composition is very
similar to the Environmental Protection Agency profile
for light diesel exhaust, with the exception of the NO to
NO2 ratio [42].
Echocardiography
Echocardiographic experiments was performed to meas-
ure heart function and chamber dimensions such as left
ventricular wall thickness (LV WT), left ventricular end
diastolic dimension (LVEDD), and left ventricular ejec-
tion fraction (LVEF, in%) using a VisualSonics VEVO
770 system equipped with a 707B scan head, as previ-
ously described [39,40]. Mice were lightly anesthetized
with 1% isoflurane when performing echocardiography.
Data were accumulated in M mode from the short axis
and LVEF (in%) was calculated as previously described
[39,40].
Gravimetric analysis
Gravimetric analysis was performed as previously de-
scribed [39,40]. The mice were euthanized by carbon di-
oxide inhalation followed by weighing, heart removal
and exsanguination. Atria were removed and ventricular
weight changes between groups were tabulated as mg
ventricular weight (VW) / g body weight (BW) and mg
ventricular weight (VW) / mm tibia length (Tibia).
Measurement of heart rate
Mice were implanted with radiotelemetric ECG de-
vices (TA10ETA-F20) from Data Sciences International
(Minneapolis, MN). The mice were anaesthetized with 2%
isofluorane. A subcutaneous pocket was made by blunt
dissection in the right flank and the transmitter inserted.
The leads were placed in a Lead II position with the cath-
ode at the right shoulder and the anode on the animal’s
left side just below the rib cage. The transmitter and leads
were sutured to secure placement and the mouse was
allowed to recover for a minimum of one week prior to
baseline data collection.
ECG, heart rate (HR) and animal activity count data
were collected using Dataquest A.R.T. software from
DataSciences, Incorporated (Minneapolis, MN). Datawere collected for 30 seconds every 5 minutes. Heart
rate was collected in beats per minute (BPM) and av-
eraged over a 12 hour time frame based on whether
the lights were on (rest) or off (wake) in the animal
room.Statistical analyses
All data were reported as mean ± SEM. The compari-
son between the groups was made by a Mann–
Whitney test with Bonferroni correction. Since we
generally made 4 pairwise comparisons for each meas-
urement, a value of p > 0.0125 was considered as no
difference between any two groups. A value of
p < 0.0125 was considered as significantly different
between groups. All the analyses were performed
using commercially available software (StatView, SAS
Institute, Inc., Cary, NC).
Sample size calculation to achieve statistical power
of 0.8 was performed through using online calculator
provided by Professor Rollin Brant, Department of
Statistics, University of British Columbia (http://www.
stat.ubc.ca/~rollin/stats/ssize/n2.html) [45].
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